Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial for 2-18 age group Ruchika Sharma5 May 2022 12:34 PM ISTThe study is likely to be conducted at six sites, including AIIMS Delhi and Patna.
Novavax seeks UK nod for Nuvaxovid use in adolescents aged 12 through 17 years Ruchika Sharma5 May 2022 11:00 AM ISTNVX-CoV2373 contains purified protein antigen and can neither replicate, nor can it cause COVID-19.
Pfizer keeps coronavirus sales forecast unchanged as pandemic curbs ease Ruchika Sharma5 May 2022 10:00 AM ISTThe company's reluctance to lift that forecast could signal a dearth of new sales contracts for the drug during the first quarter.
Serum Institute Covovax price slashed to Rs 225 Per Dose Roshni Dhar4 May 2022 5:51 PM ISTA day after its Covid shot Covovax was included on the CoWIN portal for inoculation of children aged 12-17 years at private vaccination centres, the...
Health Bulletin 4/May/2022 Roshni Dhar4 May 2022 5:24 PM ISTHere are the top health stories for the day: Mandatory yoga for MBBS: NMC releases common yoga protocol to be followed by allReferring to...
Serum Institute Covovax price cut to Rs 225 per dose Ruchika Sharma4 May 2022 1:26 PM ISTThe price of the vaccine, Covovax, is learnt to have been revised on the CoWIN portal.
SC finds no haste in granting EUA to covishield, covaxin MD Bureau3 May 2022 1:08 PM ISTThe bench said: "The material provided by the Union of India, comprising minutes of the meetings of the SEC, do not warrant the conclusion that...
COVID-19: Pfizer's Paxlovid fails to show benefit as preventive therapy Roshni Dhar2 May 2022 6:00 PM ISTPfizer Inc on Friday said a large trial found that its COVID-19 oral antiviral treatment Paxlovid was not effective at preventing coronavirus...
Health Bulletin 2/May/2022 Roshni Dhar2 May 2022 5:40 PM ISTHere are the top health stories for today:No medical negligence in inserting central venous catheter: Consumer court exonerates Fortis Hospital,...
NTAGI panel recommends Sputnik V first dose as precautionary dose Ruchika Sharma2 May 2022 12:56 PM ISTCurrently, there is no policy decision on providing a precaution dose to those inoculated with the Russian vaccine.
USFDA VRBPA committee to review Novavax COVID vaccine Ruchika Sharma2 May 2022 11:30 AM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2.
Pfizer's COVID drug Paxlovid fails to show benefit as preventive therapy Ruchika Sharma2 May 2022 10:58 AM ISTThe results were not statistically significant and thus possibly due to chance.
